SARS (Severe Acute Respiratory Syndrome) Enrolling by Invitation Phase 3 Trials for Oral Polio Vaccine (DB15864)

Also known as: Severe Acute Respiratory Syndrome (SARS) / Severe Acute Respiratory Syndrome / Respiratory Syndrome, Acute, Severe / SARS (Disease) / SARS-CoV-1 infection / SARS / Severe acute respiratory syndrome (disorder) / Severe acute respiratory syndrome NOS

DBCOND0127071 (SARS (Severe Acute Respiratory Syndrome))Enrolling by Invitation3 IdentifierTitlePurposeDrugs
NCT04540185A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19Prevention